Svenja Happe

Svenja Happe

Auto-generated profile, based on publicly available information

Svenja Happe

Klinikum Bremen-Ost/University of Göttingen

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Neuropsychobiology
Verified
Journal Article
Closed access
PDF file
SHSvenja Happe
Svenja Happe
CSCornelia Sauter
Cornelia Sauter
GKGerhard Kloesch
Gerhard Kloesch
BSBernd Saletu
Bernd Saletu
JZJosef Zeitlhofer
Josef Zeitlhofer
Dopaminergic agents such as ropinirole are the drugs of first choice in treating restless legs syndrome (RLS). Recently, gabapentin, a structural analogue of γ-aminobutyric acid, has also been shown to improve sensorimotor symptoms in RLS. Therefore, the tolerability and efficacy of randomized treatment with either gabapentin or ropinirole in patients with idiopathic RLS was evaluated in this 4-week open clinical trial. Patients with idiopathic RLS were treated with either 300 mg of gabapentin (n = 8) or 0.5 mg of ropinirole (n = 8) as the initial dose, and the dose was up-titrated until relief of symptoms was achieved (gabapentin mean dosage 800 ± 397 mg, range 300–1,200 mg; ropinirole mean dosage 0.78 ± 0.47 mg, range 0.25–1.50 mg). In both groups, International Restless Legs Syndrome Study Group questionnaire scores improved significantly (p ≤ 0.018), whereas the scores of the Epworth sleepiness scale remained unchanged within normal limits. Polysomnographic data showed a reduction of periodic leg movements during sleep (PLMS; p < 0.03) and PLMS index (p < 0.02) in both groups. Side effects were only mild and mostly transient. After 6–10 months of follow-up, in most patients, RLS symptoms were still improved. We conclude that gabapentin and ropinirole provide a similarly well-tolerated and effective treatment of PLMS and sensorimotor symptoms in patients with idiopathic RLS.

1 January 2012 in Frontiers in Psychiatry
Verified
Journal Article
Open access
MNMichael A. Nitsche
Michael A. Nitsche
JKJ. Koschack
J. Koschack
HPH. Pohlers
H. Pohlers
SHS. Hullemann
S. Hullemann
WPWalter Paulus
Walter Paulus
SHS. Happe
S. Happe
The prefrontal cortex is involved in mood and emotional processing. In patients suffering from depression, the left dorsolateral prefrontal cortex (DLPFC) is hypoactive, while activity of the right DLPFC is enhanced. Counterbalancing these pathological excitability alterations by repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) improves mood in these patients. In healthy subjects, however, rTMS of the same areas has no major effect, and the effects of tDCS are mixed. We aimed to evaluate the effects of prefrontal tDCS on emotion and emotion-related cognitive processing in healthy humans. In a first study, we administered excitability-enhancing anodal, excitability-diminishing cathodal, and placebo tDCS to the left DLPFC, combined with antagonistic stimulation of the right frontopolar cortex, and tested acute emotional changes by an adjective checklist. Subjective emotions were not influenced by tDCS. Emotional face identification, however, which was explored in a second experiment, was subtly improved by a tDCS-driven excitability modulation of the prefrontal cortex, markedly by anodal tDCS of the left DLPFC for positive emotional content. We conclude that tDCS of the prefrontal cortex improves emotion processing in healthy subjects, but does not influence subjective emotional state.

1 September 2002 in Age and Ageing
Verified
Journal Article
Open access
PDF file
SHSvenja Happe
Svenja Happe
KBKlaus Berger
Klaus Berger
FIFAQT Study Investigators
FAQT Study Investigators
Objectives: caregivers of patients with various diseases frequently report sleep disturbances and depressive symptoms. Care intensity for individuals with Parkinson's disease is mainly influenced by the severity of their motor impairment. The latter is associated with sleep fragmentation, nocturnal pain and cramps. These disease‐specific characteristics contribute to sleep‐related problems in patients. However, little is known about prevalence and causes of sleep disturbances in caregivers of Parkinson's disease patients. Design and setting: cross‐sectional analysis, nested within the FAQT‐Study, a prospective German cohort study evaluating determinants of quality of life in Parkinson's disease patients. Participants: we assessed 106 Parkinson's disease patients and their caregiving partners. Measurements: patients and partners were asked to fill in the Center for Epidemiologic Studies Depression Scale, the caregiver burden inventory, and the Gießener Beschwerdebogen of psychosomatic complaints. All instruments include questions about sleep related problems. Patients were examined by neurologists and classified according to established scales (UPDRS and Hoehn and Yahr scales). Results: frequent sleep disturbances were reported by 27% of all spouses. Relevant depressive symptoms were shown in 30% of spouses and 45% of Parkinson's disease patients (P<0.001). Depression scores in partners correlated with those in patients. Self‐perceived bad night‐time sleep in spouses was related to symptom severity, male gender, bad sleep in patients, and to the frequency of caregiving. Caregiver burden was identified as a mediator of the association between care intensity and bad sleep, while psychosomatic complaints were related to sleep problems independently. Conclusion: sleep disturbances are prevalent in partners of Parkinson's disease patients and influenced by their engagement in the caregiving process. Treatment optimization for motor symptoms in patients may not only contribute to improved patient sleep but also to a lower prevalence of sleep disturbances in caregivers.


1 January 2004 in CNS Drugs
Verified
Journal Article
Closed access
PDF file
SHSvenja Happe
Svenja Happe
CTClaudia Trenkwalder
Claudia Trenkwalder

1 January 2003 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SHSvenja Happe
Svenja Happe
WPWalter Pirker
Walter Pirker
GKGerhard Kloesch
Gerhard Kloesch
CSCornelia Sauter
Cornelia Sauter
JZJosef Zeitlhofer
Josef Zeitlhofer